Alongside this, a dose-specific preoperative administration of metformin to patients diagnosed with EC significantly decreased the level of insulin, IGF-1, glucose, and leptin, thereby inhibiting the cancer cell progression [101]. The gene discussed is INS; the disease is cancer.